更年期荷尔蒙疗法风险,益处和新兴选择:叙述性审查
Ana Maria Arnautu1, Vanda Roxana Nimigean2, Claudia Alexandra Nacea-Radu1
1Endocrinology Department, Bucharest University Emergency Hospital, 050098 Bucharest, Romania.
International journal of molecular sciences
|November 27, 2025
概括
更年期激素治疗 (MHT) 有效治疗热和阴道干燥,并预防骨质损失. 风险和益处因MHT类型,剂量和途径而异,需要个性化治疗计划.
科学领域:
- 生殖内分泌学和妇女健康
- 药理学和治疗学 药理学和治疗学
- 证据综合和临床指导方针
背景情况:
- 更年期激素治疗 (MHT) 仍然是治疗更年期症状的主要治疗方法.
- 当代证据综合对于优化MHT使用至关重要.
- 了解不断变化的风险和益处为临床决策提供了信息.
研究的目的:
- 审查当前关于更年期激素治疗 (MHT) 益处和风险的证据.
- 探索新兴的MHT选项及其安全概况.
- 为个人MHT处方提供指导.
主要方法:
- 对同行评审的研究和指导方针进行叙述性审查,截至2025年9月.
- 专注于最近的文学 (过去五年) 和定性综合.
- 包括主要的生物医学数据库 (MEDLINE/PubMed,Embase,Cochrane) 在内.
主要成果:
- 对于血管运动和泌尿生殖系统症状以及预防骨质损失,MHT非常有效.
- 心血管益处尚未确立;风险 (VTE,中风) 取决于路线,剂量和孕激素类型.
- 乳腺癌风险是特定于治疗方案的;埃斯特醇 (E4) 是有前途的,但需要进一步的安全数据.
结论:
- 基于患者因素,时间,路线,剂量和孕激素的个性化MHT选择是必不可少的.
- 应使用最低有效剂量,并定期重新评估.
- 像Estetrol (E4) 这样的新兴疗法需要继续研究长期的安全性和有效性.
相关概念视频
Menopause
3.5K
Menopause, a natural biological process marking the end of a woman's fertility, typically occurs between the fifth and sixth decade of life. This phase is characterized by the exhaustion of the ovarian follicle pool, leading to less responsive ovaries despite the high levels of Follicle Stimulating Hormone (FSH) and Luteinizing Hormone (LH). The consequential decrease in estrogen production results in symptoms like hot flashes, heavy sweating, headaches, hair loss, muscle pains, vaginal...
3.5K
Hormonal Regulation of the Menstrual Cycle
1.4K
The ovarian cycle regulates endometrial changes throughout a single menstrual cycle via the coordinated action of gonadotrophin-releasing hormone (GnRH) and gonadotrophins.
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH...
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH...
1.4K
Hormonal Control of the Ovarian Cycle
6.4K
The ovarian cycle is meticulously regulated by the hypothalamic-pituitary-gonadal axis. This cycle orchestrates the release of a mature oocyte, essential for reproduction.
Before puberty, the hypothalamus releases GnRH in a low frequency, low amplitude pulsatile manner. This along with the immature hypothalamic-pituitary-gonadal axis activity, results in low estrogen levels and the absence of a fully functional ovarian cycle. At puberty, GnRH secretion increases in both frequency and...
Before puberty, the hypothalamus releases GnRH in a low frequency, low amplitude pulsatile manner. This along with the immature hypothalamic-pituitary-gonadal axis activity, results in low estrogen levels and the absence of a fully functional ovarian cycle. At puberty, GnRH secretion increases in both frequency and...
6.4K
Hormonal Regulation
47.7K
Hormones regulate a significant portion of digestion through activation of the neuroendocrine system. The neuroendocrine system of digestion contains many different hormones all with multiple functions that are both, directly and indirectly, involved in digestion.
47.7K
Hormonal Regulation
35.6K
The renin-aldosterone system is an endocrine system which guides the renal absorption of water and electrolytes, thus managing blood pressure and osmoregulation. Activation of the system begins in the kidneys with a small cluster of cells adjacent to the afferent and efferent blood vessels of the renal corpuscle. As the nephrons are filtering blood, juxtaglomerular cells monitor blood pressure. If they detect a decrease in pressure, they release the hormone renin into the bloodstream.
35.6K
Cancer Therapies
9.8K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
9.8K


